Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024
September 14, 2024 03:00 ET
|
Sutro Biopharma, Inc.
- 4.3 mg/kg of luveltamab tazevibulin (luvelta) in combination with standard dose of bevacizumab (15 mg/kg) every 3 weeks resulted in a 56% objective response rate in patients with late-stage ovarian...
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
September 13, 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines
September 13, 2024 08:30 ET
|
Elicio Therapeutics Inc.
BOSTON, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel...
Kane Biotech Announces Exercise of Warrants
September 12, 2024 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the exercise of an aggregate of 5 million warrants at an...
OMINQ Secures Over $1 Million in New Purchase Orders from Prominent Bioscience Company
September 11, 2024 08:30 ET
|
omniQ Corp.
OMNIQ secures $1M+ in new orders from a key bioscience partner, celebrating 20 years of collaboration and boosting global innovation with AI solutions.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
September 11, 2024 08:00 ET
|
Halberd Corp.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection
September 11, 2024 04:51 ET
|
SOLASTA Bio Ltd.
SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A
Culture Biosciences and Google Cloud Announce Collaboration to Revolutionize Bioprocess Development
September 10, 2024 10:00 ET
|
Culture Biosciences
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Culture Biosciences—a leader in automated bioprocess development, optimization and data science —announces a strategic...
Tersa Earth Partners with Wet’suwet’en First Nation to Advance Sustainable Economic Growth
September 10, 2024 09:03 ET
|
Tersa Earth Innovations Inc
Tersa Earth Innovations Inc. is excited to announce a strategic partnership with Yinka Dene Economic Development Limited Partnership (YLP).
Abivax presents first-half 2024 financial results
September 09, 2024 16:01 ET
|
Abivax
Abivax presents first-half 2024 financial results Cash balance of EUR 222M at June 30, 2024; cash runway in to Q4 2025 PARIS, France, September 9, 2024, 10:00 p.m. CEST – Abivax SA...